Analysis of workload generated in the two years following first consultation by each new cancer patient: studying the past to plan the future of cancer care.

Autor: Garattini, SK.¹ (AUTHOR) silvioken.garattini@asufc.sanita.fvg.it, Valent, F.² (AUTHOR), Minisini, AM.¹ (AUTHOR), Riosa, C.¹ (AUTHOR), Favaretti, C.³ (AUTHOR), Regattin, L.⁴ (AUTHOR), Fasola, G.¹ (AUTHOR), Garattini, S K⁵ (AUTHOR), Minisini, A M⁵ (AUTHOR)

Publikováno v: BMC Health Services Research. 9/21/2022, Vol. 22 Issue 1, p1-8. 8p. 4 Charts.

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Autor: Marilina Duro, Sara Pusceddu, Anna La Salvia, Paola Ermacora, Laura Concas, Natalie Prinzi, Annalisa Fontana, Filippo de Braud, Salvatore Tafuto, Giuseppe Lo Russo, Vincenzo Mazzaferro, Francesca Spada, Rossana Berardi, Dario Giuffrida, Emilio Bajetta, Maria Rinzivillo, P. Razzore, Claudio Vernieri, Antongiulio Faggiano, Luca Giacomelli, Francesco Panzuto, Vittorio Perfetti, Massimo Di Maio, Francesca Aroldi, Francesco Di Costanzo, Lorenzo Antonuzzo, Daniela Femia, Gianfranco Delle Fave, Massimo Milione, Silvio Ken Garattini, Carlo Carnaghi, Roberto Buzzoni, Nicole Brighi, Sara Cingarlini, Carolina Cauchi, Mariangela Torniai, Silvia Ortolani, Nicola Fazio, Chiara De Divitiis, Laura Catena, Ivana Puliafito, Federica Cavalcoli, Maria Pia Brizzi, Alberto Zaniboni, Sergio Ricci, Maria Vittoria Davì, Alberto Bongiovanni, Davide Campana, Toni Ibrahim, Riccardo Marconcini, Sara Massironi, Annamaria Colao

Publikováno v: Gastroenterology. 155(2)

BACKGROUND & AIMS: Metformin seems to have anticancer effects. However, it is not clear whether use of glycemia and metformin affect outcomes of patients with advanced pancreatic neuroendocrine tumors (pNETs). We investigated the association between

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dcfecbab2c6a6d2cb38f547e8767c26
https://pubmed.ncbi.nlm.nih.gov/29655834

Clinical Application of Radiomics in Oncology: Where Do We Stand?

Autor: Pascuzzo R; Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Garattini SK; Department of Medical Oncology, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine, Italy., Doniselli FM; Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Publikováno v: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Dec; Vol. 60 (6), pp. 2745-2746. Date of Electronic Publication: 2024 Mar 13.

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.

Autor: Rimini M; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Masi G; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Lonardi S; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Pressiani T; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Lavacchi D; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Jessica L; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy., Giordano G; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Scartozzi M; Medical Oncology, University and University Hospital, Cagliari, Italy., Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy., Pastorino A; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy., Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Daniele B; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy., Martinelli E; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy., Garajova I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy., Schirripa M; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy., Formica V; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy., Salani F; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Winchler C; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Bergamo F; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Balsano R; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy., Gusmaroli E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy., Lorenzo A; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy., Landriscina M; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Pretta A; Medical Oncology, University and University Hospital, Cagliari, Italy., Toma I; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy., Pirrone C; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy., Diana A; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy., Leone F; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy., Brunetti O; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy., Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy., Garattini SK; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy., Satolli MA; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Rossari F; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Fornaro L; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy., Zanuso V; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., De Rosa A; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy.; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Medical Oncology, University and University Hospital, Cagliari, Italy.; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy.; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy.; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy.; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Surgery, oncology and gastroenterology of Padua, Padua, Italy., Ratti F; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Milan, Italy., Aldrighetti L; Vita-Salute San Raffaele University, Milan, Italy., De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy.; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Medical Oncology, University and University Hospital, Cagliari, Italy.; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy.; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy.; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy.; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Surgery, oncology and gastroenterology of Padua, Padua, Italy.; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Foti S; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Rizzato MD; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Vivaldi C; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Stefano C; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Rimassa L; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy. casadeigardini@gmail.com.; Department of Medical Oncology, IRCCS San Raffaele Hospital, Via Olgettina n. 60, Milan, Italy. casadeigardini@gmail.com.

Publikováno v: Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 359-370. Date of Electronic Publication: 2024 May 01.

Pemigatinib for patients with previously treated, locally advanced or metastatic cholangiocarcinoma harboring FGFR2 fusions or rearrangements: A joint analysis of the French PEMI-BIL and Italian PEMI-REAL cohort studies.

Autor: Parisi A; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy. Electronic address: alexparis@hotmail.it., Delaunay B; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France., Pinterpe G; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Hollebecque A; Département d'Innovation Thérapeutique et Essais précoces (DITEP), Gustave Roussy, Villejuif Cedex, France., Blanc JF; Oncology Digestive Unit, Hôpital haut-Lévêque, CHU Bordeaux France, France., Bouattour M; Liver Oncology and Therapeutic Innovation Functional Unit, Beaujon Hospital APHP, Clichy, France., Assenat E; Medical oncology, ICM - Institut du Cancer de Montpellier, Montpellier Cedex, France., Ben Abdelghani M; Oncology Department, ICANS - Institut de Cancérologie Strasbourg Europe, Strasbourg, France., Sarabi M; Medical Oncology, Centre Léon Bérard, Lyon, GI Oncology Department, France; GI Oncology Department, Hôpital privé Jean Mermoz, Lyon, France., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, 20133 Milan, Italy., Vivaldi C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy., Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy., Palloni A; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Bensi M; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Italy; Università Cattolica del Sacro Cuore, Roma, Italy., Garattini SK; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, Udine, UD 33100, Italy., Tougeron D; Université de Poitiers, Department of Gastroenterology and Hepatology, Poitiers University Hospital, Poitiers, France., Combe P; Medical Oncology, CORT37, Pôle Santé Léonard de Vinci, Chambray-lès-Tours, France., Salati M; Division of Oncology, Department of Oncology and Hematology, University Hospital Modena, Modena Cancer Centre, Via del Pozzo 71, 41125 Modena, Italy; Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy., Rimini M; Vita-Salute University San Raffaele, Milan, Italy; Department of Oncology, IRCCS San Raffaele Hospital, via Olgettina N. 60, Milan 20132, Italy., Cella CA; Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO IRCCS, Via Ripamonti 435, Milan, Italy., Tucci M; Department of Interdisciplinary Medicine, Oncology Unit, University of Bari 'Aldo Moro', P.za Giulio Cesare, 11, 70124, Bari, Italy., Diana A; UOC Oncologia - Ospedale del Mare, Naples., Mori E; Department of Medical Oncology, New Hospital of Prato S. Stefano, 59100 Prato, Italy., Longarini R; Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Artru P; GI Oncology Department, Hôpital privé Jean Mermoz, Lyon, France., Roth G; Univ. Grenoble Alpes / Hepato-Gastroenterology and Digestive Oncology Department, CHU Grenoble Alpes / Institute for Advanced Biosciences, CNRS UMR 5309-INSERM, U1209, France., Evesque L; Medical Oncology Department, Centre Antoine-Lacassagne, Nice, France., Vienne A; Oncology Department, CHU Sud Réunion, Saint Pierre, France., Turpin A; Medical Oncology Department, Hopital Claude Huriez, Lille, France., Hiret S; Oncology Department, ICO Institut de Cancerologie de l'Ouest René Gauducheau, Saint-Herblain, France., Bourgeois V; Digestive Oncology, Hopital duchenne Boulogne-sur-Mer, France., Herve C; Digestive Oncology, Groupe Hospitalier Mutualiste, Grenoble., Paulon R; Medical Oncology, Clinique du Sidobre, Castres, France., Stacoffe M; Medical Oncology, CHRU Hopitaux de Tours - Hopital Bretonneau, Tours Cedex, France., Malka D; Medical Oncology, Institut Mutualiste Montsouris, Paris, France., Neuzillet C; GI Oncology, Medical Oncology Department, Curie Institute, Paris, France., Edeline J; Medical Oncology Department, Centre Eugene - Marquis, Rennes, France., Lievre A; Department of Gastroenterology, CHU de Rennes - Hopital Pontchaillou, Rennes Cedex, France., Guimbaud R; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France., Chapda MCP; MeDatas, CIC (Centre d'Investigation Clinique), CHU Toulouse, Toulouse, France., Rimassa L; Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, Milan, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy., Giampieri R; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Valle J; Cholangiocarcinoma Foundation, Salt Lake City, Utah, USA; Division of Cancer Sciences, University of Manchester, Manchester, UK., Berardi R; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, Azienda Ospedaliero-Universitaria delle Marche, Via Conca 71, 60126 Ancona, Italy., Fares N; Digestive Oncology Department, Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil, Toulouse, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 200, pp. 113587. Date of Electronic Publication: 2024 Feb 06.